The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:52
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [1] Impact of Postoperative Radiation after Esophagectomy for Esophageal Cancer
    Schreiber, David
    Rineer, Justin
    Vongtama, Dan
    Wortham, Angela
    Han, Peter
    Schwartz, David
    Choi, Kwang
    Rotman, Marvin
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 244 - 250
  • [2] Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer
    Xu, Yaping
    Liu, Jinshi
    Du, Xianghui
    Sun, Xiaojiang
    Zheng, Yuanda
    Chen, Jianxiang
    Li, Bo
    Liu, Wei
    Jiang, Hao
    Mao, Weimin
    RADIATION ONCOLOGY, 2013, 8
  • [3] The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma
    Rucker, A. Justin
    Raman, Vignesh
    Jawitz, Oliver K.
    Voigt, Soraya L.
    Harpole, David H.
    D'Amico, Thomas A.
    Tong, Betty C.
    ANNALS OF SURGERY, 2022, 275 (02) : 348 - 355
  • [4] Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer
    Burt, Bryan M.
    Groth, Shawn S.
    Sada, Yvonne H.
    Farjah, Farhood
    Cornwell, Lorraine
    Sugarbaker, David J.
    Massarweh, Nader N.
    ANNALS OF SURGERY, 2017, 266 (02) : 297 - 304
  • [5] Adjuvant (Postoperative) Therapy for Esophageal Cancer
    Ku, Geoffrey Y.
    Ilson, David H.
    THORACIC SURGERY CLINICS, 2013, 23 (04) : 525 - +
  • [6] Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinoma
    Jeon, Yeong Jeong
    Cho, Jong Ho
    Choi, Yong Soo
    Shim, Young Mog
    Sun, Jong-Mu
    Kim, Hong Kwan
    THORACIC CANCER, 2023, 14 (06) : 624 - 635
  • [7] Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma A Network Meta-analysis
    Pasquali, Sandro
    Yim, Guang
    Vohra, Ravinder S.
    Mocellin, Simone
    Nyanhongo, Donald
    Marriott, Paul
    Geh, Ju Ian
    Griffiths, Ewen A.
    ANNALS OF SURGERY, 2017, 265 (03) : 481 - 491
  • [8] Survival After Induction Chemotherapy and Esophagectomy Is Not Improved by Adjuvant Chemotherapy
    Yan, Wanpu
    Zhao, Peiliang
    Fu, Hao
    Lin, Yao
    Li, Zhongwu
    Dai, Liang
    Yang, Yongbo
    Kang, Xiaozheng
    Chen, Ke-Neng
    ANNALS OF THORACIC SURGERY, 2019, 108 (05) : 1505 - 1513
  • [9] Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma
    Qiu, Bo
    Li, JiaXiang
    Wang, Bin
    Wang, ZhiQiang
    Liang, Ying
    Cai, Peiqiang
    Chen, ZhaoLin
    Liu, MengZhong
    Fu, JianHua
    Yang, Hong
    Liu, Hui
    JOURNAL OF CANCER, 2017, 8 (02): : 249 - 257
  • [10] Radiation therapy does not improve survival in patients who are upstaged after esophagectomy for clinical early-stage esophageal adenocarcinoma
    Kamtam, Devanish N.
    Lin, Nicole
    Liou, Douglas Z.
    Lui, Natalie S.
    Backhus, Leah M.
    Shrager, Joseph B.
    Berry, Mark F.
    JTCVS OPEN, 2025, 23 : 290 - 308